The tumor microenvironment, mainly the immunohistochemical expression of CD3 and CD8 lymphocytes, was investigated in gastrointestinal stromal tumors and Ewing sarcoma, demonstrating that increased levels of these markers correlate with better survival and can be considered prognostic factors [9,10]. This evidence concerns the gene CD8A and gastrointestinal stromal tumor.